Insulet Corporation—a medical company specializing in tubeless insulin pump technology—has made their tubeless Automated Insulin Delivery (AID) System called Omnipod 5 widely available through retail pharmacies across the US. This development has made the AID system more accessible for people with Type 1 diabetes.
Omnipod 5 is an insulin delivery system that easily integrates with the Dexcom G6 CGM system and adjusts insulin delivery automatically every 5 minutes. This process helps eliminate lows or highs in blood glucose levels. The system also makes insulin delivery convenient by removing the need for multiple daily injections without compromising the outcomes. It minimizes glucose spikes, a common occurrence for people who use insulin pens. By preventing low blood sugar, Omnipod 5 helps improve the energy and focus of the patients.
Moreover, this tubeless AID provides the choice between using a compatible smartphone or a separate Omnipod 5 Controller that comes with the device. Insulet is enhancing its list of compatible smartphones to ensure this option has maximum availability for diabetic patients.
Notably, devices available through the DME channel have a higher upfront cost and a four-year lock-in period. Now with Omnipod 5’s availability at retail pharmacies, the device has become simpler to access for people with type 1 diabetes.
when will the Omnipod 5 with Dexcom 6 be available for type 2 users?
I have no information about that. My best suggestion is to contact Insulet Corporation directly for more details. My suspicion is that it is a question of FDA clearance, but I don’t know that for a fact.
All the best,
Alfred Poor, Editor
Health Tech Insider